Search clinical trials for: PD-1 Inhibitors
Total 103509 results
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
Aiping ShiRecruitingTriple Negative Breast Cancer (TNBC)China
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical UniversityActive, not recruitingBiliary Tract CarcinomaChina
-
University Hospital, LilleINSERM U1189 ONCOTHAIRecruitingMalignant Pleural Mesothelioma | Mesotheliomas PleuralFrance
-
Shi MingSuspended
-
Beijing Friendship HospitalRecruitingLocally Advanced Rectal CancerChina
-
Coherus Biosciences, Inc.Shanghai Junshi Bioscience Co., Ltd.; Medpace, Inc.Active, not recruitingHepatocellular Carcinoma | Non-Small Cell Lung Cancer | Advanced Solid TumorUnited States
-
Agenus Inc.Withdrawn
-
Second Military Medical UniversityUnknownAdvanced Hepatocellular CarcinomaChina
-
Peking UniversityNot yet recruiting
-
The First Hospital of Jilin UniversityRecruiting
-
Fujian Cancer HospitalSuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingEsophageal Neoplasms | Esophageal Squamous Cell CarcinomaChina
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
University of PadovaDepartment of Ophthalmology, Conegliano Hospital, Treviso, ItalyUnknownNeovascular Age-Related Macular DegenerationItaly
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchNot yet recruitingPD-1 Refractory Advanced MelanomaUnited States
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Merck Sharp & Dohme LLCActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Matthew GalskyMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
Hoffmann-La RocheRecruitingPD-L1-selected Solid TumorsSpain, Korea, Republic of, China, Taiwan, Turkey, Greece, United States, Croatia, Serbia, Canada, Mexico, Cyprus, Georgia
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
AnaptysBio, Inc.Recruiting
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingUterine Cervical NeoplasmsCanada, United States, Australia, Austria, Belgium, Brazil, Chile, China, Colombia, Czechia, France, Germany, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Norway, Peru, Russian Federation, Spain, Sweden, ... and more
-
Nanfang Hospital of Southern Medical UniversityRecruiting
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
AnaptysBio, Inc.RecruitingRheumatoid ArthritisUnited States, Argentina, Estonia, Georgia, Hungary, Mexico, Moldova, Republic of, Peru, Poland, Slovakia, Belgium, Canada, Germany, Italy, Spain
-
Chinese PLA General HospitalUnknown
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Henlix, IncUnknown
-
Peking Union Medical College HospitalRecruitingAnlotinib | Anti-PD-1 Antibody | Advanced Pancreatic CancerChina
-
Peking University Third HospitalUnknown
-
Henan Cancer HospitalRecruitingClassical Hodgkin LymphomaChina
-
SecuraBioTerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Fudan UniversityZhejiang Cancer Hospital; Xijing Hospital; Shanghai Zhongshan Hospital; Tongji...Recruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Fujian Cancer HospitalNot yet recruitingLung Adenocarcinoma | PD-1 Inhibitor | Stage IV Non-small Cell Lung Cancer | VEGF
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Stereotactic Body Radiotherapy | Low Dose RadiotherapyChina
-
National Cancer Institute (NCI)Recruiting
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Kristoffer RohrbergRecruitingMetastatic Cancer | Solid Tumor, AdultDenmark
-
Beijing Tongren HospitalRecruitingT-lymphoblastic Lymphoma | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Yunfei YuanCompletedHepatocellular CarcinomaChina